Related Experiment Videos
Analgesic and anti-inflammatory therapy in the elderly
The American Journal of Medicine
|October 18, 1985
Summary
Elderly individuals often experience musculoskeletal pain, necessitating careful medication management. Physicians must consider age-related physiological changes when prescribing drugs for conditions like osteoarthritis to minimize toxicity.
Area of Science:
- Gerontology
- Rheumatology
- Clinical Pharmacology
Background:
- Musculoskeletal complaints affect two-thirds of Americans aged 65 and older.
- Osteoarthritis is a prevalent rheumatic disease in the elderly population.
- Over-the-counter (OTC) medications are frequently used for discomfort relief.
Purpose of the Study:
- To highlight the importance of understanding aging physiology in drug therapy for elderly patients.
- To emphasize the principle of least toxicity in prescribing medications for older adults.
- To guide physicians on managing drug therapy for elderly patients with osteoarthritis.
Main Methods:
- Review of physiological aspects of aging relevant to drug pharmacokinetics.
- Analysis of pharmacokinetic activity of common agents used in the elderly.
- Emphasis on individualized dosage titration based on patient-specific factors.
Main Results:
- Physiological changes in aging significantly impact drug pharmacokinetics.
- Drug therapy in the elderly requires careful consideration of potential toxicities.
- Dosage titration is crucial when drug pharmacokinetic data is limited.
Conclusions:
- Physicians must integrate knowledge of aging physiology into osteoarthritis treatment plans.
- Prioritizing least toxicity and careful dosage titration is essential for safe and effective drug therapy in older adults.
- Awareness of pharmacokinetic alterations is key to managing rheumatic diseases in the elderly.